Applied Therapeutics Inc. (NASDAQ: APLT)
$5.93
+0.3800 ( +6.85% ) 1.1M
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Market Data
Open
$5.93
Previous close
$5.55
Volume
1.1M
Market cap
$678.75M
Day range
$4.83 - $6.03
52 week range
$1.18 - $9.39
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
8-k | 8K-related | 70 | Mar 11, 2024 |
8-k | 8K-related | 16 | Mar 06, 2024 |
10-k | Annual reports | 114 | Mar 06, 2024 |
8-k | 8K-related | 19 | Feb 29, 2024 |
8-k | 8K-related | 14 | Feb 15, 2024 |
8-k | 8K-related | 12 | Jan 04, 2024 |